In conclusion, we found that FOXM1 directly regulated EXO1 expression to promote the DNA repair pathway upon cisplatin treatment, and demonstrated that FOXM1 knockdown can enhance sensitivity of ovarian cancer cells to cisplatin. This evidence concerns the gene FOXM1 and ovarian carcinoma.